Reversible Kinetic Analysis of Myc Targets Offers Novel Insights into Tumorigenesis

Researchers from the University of California, San Francisco have made a groundbreaking discovery in the field of cancer research by employing reversible kinetic analysis of Myc targets in vivo. This innovative approach has provided novel insights into Myc-mediated tumorigenesis, a process in which deregulated expression of the Myc transcription factor is a frequent causal mutation in human cancer. The study has shed light on the complex and diverse nature of Myc gene targets, highlighting the need for an unbiased strategy to identify critical targets mediating Myc-driven tumorigenesis in vivo.

Key Takeaways:

• The study utilized a reversibly switchable transgenic model of Myc-mediated beta cell tumorigenesis to induce rapid tumor onset and regression, demonstrating the requirement of sustained Myc activity for tumor maintenance.
• The researchers employed high-density oligonucleotide microarrays to develop an unbiased strategy for identifying candidate Myc-regulated genes responsible for maintenance of Myc-dependent tumors.
• The study revealed that Myc-regulated genes involved in cell growth, cycle, and proliferation were consistent with known Myc functions, while many Myc-regulated genes were specific to beta cells, indicating a cell type-specific component of Myc action.
• A restricted cadre of genes with expression inversely regulated upon Myc activation-induced tumor progression and deactivation-induced tumor regression was identified as candidates for tumor maintenance functions.
• Combining reversibly switchable, transgenic models of tumor formation and regression with genomic profiling offers a novel strategy for deconvoluting the complexities of oncogenic signaling pathways in vivo.

Statistics:

• Thousands of putative Myc target genes have been identified in in vitro studies, indicating the highly pleiotropic effects of Myc within cells and tissues.
• The reversibly switchable transgenic model of Myc-mediated beta cell tumorigenesis induced a rapid tumor onset within days, followed by equally rapid tumor regression upon deactivation of Myc.
• High-density oligonucleotide microarrays were used to analyze the expression of over 20,000 genes, allowing for the identification of candidate Myc-regulated genes.

Sources:

• Lawlor, E. R., et al. (2006). Reversible kinetic analysis of Myc targets in vivo provides novel insights into Myc-mediated tumorigenesis. Cancer Research, 66(9), 4591-4601.
• E.R. Lawlor and colleagues, University of California, San Francisco.
• American Association of Cancer Research, 615 Chestnut St., 17th Floor, Philadelphia, PA 19106-4404, USA.